PhD Genomic Medicine in Newtownabbey United Kingdom | Ulster University

The Genomic Medicine Research Group specializes in applying genetic insights and advanced technologies to deepen our comprehension of human illnesses, aiming to refine diagnostic methods and therapeutic approaches for complex conditions. Our scientists concentrate on epigenetics, microRNA functions, and genetic variations that influence disease progression. Employing diverse experimental and computational methods, our collaborative projects conduct pioneering studies across multiple fields such as oncology, ophthalmology, cardiology, and psychiatry. We leverage cutting-edge tools from the Genomics Core Facility Unit, featuring flow cytometry, imaging systems, PCR technology, sequencing platforms, and methylation analysis equipment. Our research incorporates distinctive cellular and animal models, along with techniques like CRISPR/Cas genome editing, gene suppression, DNA methylation profiling, and reporter gene assays. Bioinformatics capabilities within our team enhance this experimental work, enabling large-scale genetic association studies and analysis of open-access genomic data.

Our team maintains productive partnerships with academic institutions, healthcare providers, and industry leaders worldwide, consistently generating impactful publications and presenting at international conferences. As genomic science plays a pivotal role in advancing precision healthcare, Ulster's Genomic Medicine Research Group is committed to driving this progress. Our mission focuses on bridging laboratory discoveries with clinical applications, realizing the transformative potential of genomic medicine for patient care.